With regard to type 2 diabetes, AVP may directly stimulate metabolism including hepatic glucose production [77] or insulin release from the pancreas [78] and may adversely affect whole-body responses to insulin [79]. This evidence concerns the gene INS and type 2 diabetes mellitus.